Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Pretax income is the income that a company earns before paying income taxes. Asian Phytoceuticals PCL's pretax income for the
three
months ended in Mar. 2026 was ฿22.1 Mil.
Its pretax income for the trailing twelve months (TTM) ended in Mar. 2026 was ฿76.3 Mil.
Asian Phytoceuticals PCL's pretax margin was 44.61%.
During the past 13 years, Asian Phytoceuticals PCL's highest Pretax Margin was 45.49%. The lowest was 29.22%. And the median was 35.00%.
Asian Phytoceuticals PCL (BKK:APCO-R) Pre-Tax Income Explanation
Asian Phytoceuticals PCL's Pretax Margin for the quarter that ended in Mar. 2026 is calculated as
During the past 13 years, Asian Phytoceuticals PCL's highest Pretax Margin was 45.49%. The lowest was 29.22%. And the median was 35.00%.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Asian Phytoceuticals PCL Pre-Tax Income Related Terms
Asian Phytoceuticals PCL Pre-Tax Income Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BKK:APCO-R vs PG, CL, KVUE: Pre-Tax Income Comparison
For the Household & Personal Products subindustry, Asian Phytoceuticals PCL's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Asian Phytoceuticals PCL Pre-Tax Income vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Asian Phytoceuticals PCL's Pre-Tax Income distribution charts can be found below:
* The bar in red indicates where Asian Phytoceuticals PCL's Pre-Tax Income falls into.
Pre-Tax Income for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿76.3 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Asian Phytoceuticals PCL (BKK:APCO-R) has a Pre-Tax Income of ฿76.3 Mil as of Mar. 2026. Pre-Tax Income is the total earnings before taxes but after all operating and interest expenses. View historical data on Asian Phytoceuticals PCL and its competitors.
Is Asian Phytoceuticals PCL's Pre-Tax Income too high?
Asian Phytoceuticals PCL's current Pre-Tax Income is ฿76.3 Mil. Overall, Asian Phytoceuticals PCL has a GF Score™ of 62/100, reflecting its overall financial health beyond just this single metric.
How does Asian Phytoceuticals PCL's Pre-Tax Income compare to PG and CL?
Asian Phytoceuticals PCL's Pre-Tax Income of ฿76.3 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pre-Tax Income for a Consumer Packaged Goods company?
A good Pre-Tax Income depends on the Consumer Packaged Goods industry context. However, Pre-Tax Income should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pre-Tax Income mean?
A high Pre-Tax Income can signal that a stock is expensive relative to its fundamentals. Pre-Tax Income is the total earnings before taxes but after all operating and interest expenses. View historical data on Asian Phytoceuticals PCL and its competitors. Asian Phytoceuticals PCL's current Pre-Tax Income is ฿76.3 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Asian Phytoceuticals PCL stock overvalued right now?
Asian Phytoceuticals PCL (BKK:APCO-R) has a current Pre-Tax Income of ฿76.3 Mil. The stock's GF Value™ is ฿7.41, compared to a current price of ฿6.27 — trading 15.3% below its estimated fair value. The current Pre-Tax Income is ฿76.3 Mil. Asian Phytoceuticals PCL's overall GF Score™ is 62/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pre-Tax Income calculated?
Pre-Tax Income is calculated from a company's financial statements. For Asian Phytoceuticals PCL (BKK:APCO-R), the current Pre-Tax Income is ฿76.3 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Asian Phytoceuticals PCL (BKK:APCO-R) Overvalued in 2026?
Based on GuruFocus' analysis, Asian Phytoceuticals PCL stock appears to be undervalued.
The current stock price of ฿6.27 is trading 15.3% below its estimated GF Value™ of ฿7.41.
Key valuation signals for BKK:APCO-R:
Pre-Tax Income: ฿76.3 Mil
GF Value™: ฿7.41 vs. price of ฿6.27 (15.3% below fair value)
No single metric tells the full story. See the BKK:APCO-R stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Asian Phytoceuticals PCL engages in the manufacturing and marketing of herbal healthcare products. The company engages in the production and distribution of dietary supplements, cosmetics, and personal care products made from natural herbs. Its beauty products include skin nourishing and skin care products, hair loss treatment and hair growth products, slimming products, dietary supplements, and other nutritional products. Geographically, the company offers its services only in Thailand.
62GF Score
Get the complete analysis for BKK:APCO-R
Pre-Tax Income is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:APCO-R has been successfully added to your 
